- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Vaccine Conjugate industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
SutroVax Inc
Fablife
Sanofi Pasteur SA
Pfizer
GlaxoSmithKline plc
Sinovac Biotech Ltd
By Type:
Monovalent
Multivalent
Others
By Application:
Meningococcal
Influenza
Others
Pneumococcal
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Vaccine Conjugate Market Overview 2018-2029
-
1.1 China Vaccine Conjugate Industry Development Overview
-
1.2 China Vaccine Conjugate Industry Development History
-
1.3 China Vaccine Conjugate Industry Market Size (2018-2029)
-
1.4 China Vaccine Conjugate Market Analysis by Type from Production Side
-
1.4.1 China Vaccine Conjugate Production Volume, Production Value and Growth Rate of Monovalent (2018-2029)
-
1.4.2 China Vaccine Conjugate Production Volume, Production Value and Growth Rate of Multivalent (2018-2029)
-
1.4.3 China Vaccine Conjugate Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.5 China Vaccine Conjugate Market Analysis by Application from Consumption End
-
1.5.1 China Vaccine Conjugate Sales Volume, Sales Value and Growth Rate of Meningococcal (2018-2029)
-
1.5.2 China Vaccine Conjugate Sales Volume, Sales Value and Growth Rate of Influenza (2018-2029)
-
1.5.3 China Vaccine Conjugate Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.5.4 China Vaccine Conjugate Sales Volume, Sales Value and Growth Rate of Pneumococcal (2018-2029)
-
1.6 China Vaccine Conjugate Market Analysis by Region
-
1.6.1 North China Vaccine Conjugate Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Vaccine Conjugate Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Vaccine Conjugate Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Vaccine Conjugate Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Vaccine Conjugate Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Vaccine Conjugate Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Vaccine Conjugate Market Size and Growth Rate from 2018-2029
Chapter 2 China Vaccine Conjugate Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Vaccine Conjugate Market Status and Competition at home and abroad in 2023
-
2.2.2 China Vaccine Conjugate Market Status and Competition Analysis in 2023
-
2.2.3 China Vaccine Conjugate Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Vaccine Conjugate Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Vaccine Conjugate Industry Development
Chapter 3 Vaccine ConjugateIndustry Chain Analysis
-
3.1 Vaccine Conjugate Industry Chain
-
3.2 Vaccine Conjugate Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Vaccine Conjugate Market
-
3.3 Vaccine Conjugate Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Vaccine Conjugate Market
Chapter 4 China Vaccine Conjugate Market, by Type
-
4.1 China Vaccine Conjugate Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Vaccine Conjugate Total Production Volume and Growth Rate from Production Side
-
4.5 China Vaccine Conjugate Production Volume and Growth Rate, by Type
-
4.5.1 China Vaccine Conjugate Production Volume and Growth Rate of Monovalent
-
4.5.2 China Vaccine Conjugate Production Volume and Growth Rate of Multivalent
-
4.5.3 China Vaccine Conjugate Production Volume and Growth Rate of Others
Chapter 5 China Vaccine Conjugate Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Vaccine Conjugate Total Market Size and Growth Rate from Consumption End
-
5.5 China Vaccine Conjugate Market Size and Growth Rate, by Application
-
5.5.1 China Vaccine Conjugate Market Size and Growth Rate of Meningococcal
-
5.5.2 China Vaccine Conjugate Market Size and Growth Rate of Influenza
-
5.5.3 China Vaccine Conjugate Market Size and Growth Rate of Others
-
5.5.4 China Vaccine Conjugate Market Size and Growth Rate of Pneumococcal
Chapter 6 China Vaccine Conjugate Market, by Region
-
6.1 China Vaccine Conjugate Production Volume and Production Value, by Region
-
6.2 China Vaccine Conjugate Sales Volume and Sales Value, by Region
Chapter 7 North China Vaccine Conjugate Market Analysis
-
7.1 North China Vaccine Conjugate Market, by Type
-
7.2 North China Vaccine Conjugate Market, by Application
Chapter 8 Central China Vaccine Conjugate Market Analysis
-
8.1 Central China Vaccine Conjugate Market, by Type
-
8.2 Central China Vaccine Conjugate Market, by Application
Chapter 9 South China Vaccine Conjugate Market Analysis
-
9.1 South China Vaccine Conjugate Market, by Type
-
9.2 South China Vaccine Conjugate Market, by Application
Chapter 10 East China Vaccine Conjugate Market Analysis
-
10.1 East China Vaccine Conjugate Market, by Type
-
10.2 East China Vaccine Conjugate Market, by Application
Chapter 11 Northeast China Vaccine Conjugate Market Analysis
-
11.1 Northeast China Vaccine Conjugate Market, by Type
-
11.2 Northeast China Vaccine Conjugate Market, by Application
Chapter 12 Southwest China Vaccine Conjugate Market Analysis
-
12.1 Southwest China Vaccine Conjugate Market, by Type
-
12.2 Southwest China Vaccine Conjugate Market, by Application
Chapter 13 Northwest China Vaccine Conjugate Market Analysis
-
13.1 Northwest China Vaccine Conjugate Market, by Type
-
13.2 Northwest China Vaccine Conjugate Market, by Application
Chapter 14 Company Profiles
-
14.1 SutroVax Inc
-
14.1.1 SutroVax Inc Company Profile
-
14.1.2 SutroVax Inc Vaccine Conjugate Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Fablife
-
14.2.1 Fablife Company Profile
-
14.2.2 Fablife Vaccine Conjugate Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Sanofi Pasteur SA
-
14.3.1 Sanofi Pasteur SA Company Profile
-
14.3.2 Sanofi Pasteur SA Vaccine Conjugate Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Pfizer
-
14.4.1 Pfizer Company Profile
-
14.4.2 Pfizer Vaccine Conjugate Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 GlaxoSmithKline plc
-
14.5.1 GlaxoSmithKline plc Company Profile
-
14.5.2 GlaxoSmithKline plc Vaccine Conjugate Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Sinovac Biotech Ltd
-
14.6.1 Sinovac Biotech Ltd Company Profile
-
14.6.2 Sinovac Biotech Ltd Vaccine Conjugate Market Performance
-
14.6.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Vaccine Conjugate Industry Research Conclusions
-
15.2 Vaccine Conjugate Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Vaccine Conjugate Industry Market Size (2018-2029)
-
Figure China Vaccine Conjugate Production Volume, Production Value and Growth Rate of Monovalent (2018-2029)
-
Figure China Vaccine Conjugate Production Volume, Production Value and Growth Rate of Multivalent (2018-2029)
-
Figure China Vaccine Conjugate Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Vaccine Conjugate Sales Volume, Sales Value and Growth Rate of Meningococcal (2018-2029)
-
Figure China Vaccine Conjugate Sales Volume, Sales Value and Growth Rate of Influenza (2018-2029)
-
Figure China Vaccine Conjugate Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure China Vaccine Conjugate Sales Volume, Sales Value and Growth Rate of Pneumococcal (2018-2029)
-
Figure North China Vaccine Conjugate Market Size and Growth Rate from 2018-2029
-
Figure Central China Vaccine Conjugate Market Size and Growth Rate from 2018-2029
-
Figure South China Vaccine Conjugate Market Size and Growth Rate from 2018-2029
-
Figure East China Vaccine Conjugate Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Vaccine Conjugate Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Vaccine Conjugate Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Vaccine Conjugate Market Size and Growth Rate from 2018-2029
-
Figure Vaccine Conjugate Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Vaccine Conjugate Market Share by Type in 2018
-
Figure China Vaccine Conjugate Market Share by Type in 2023
-
Figure China Vaccine Conjugate Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Vaccine Conjugate Production Volume and Growth Rate of Monovalent (2018-2023)
-
Figure China Vaccine Conjugate Production Volume and Growth Rate of Multivalent (2018-2023)
-
Figure China Vaccine Conjugate Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Vaccine Conjugate Market Share by Application in 2018
-
Figure China Vaccine Conjugate Market Share by Application in 2023
-
Figure China Vaccine Conjugate Total Market Size and Growth Rate from Consumption End
-
Figure China Vaccine Conjugate Market Size and Growth Rate of Meningococcal (2018-2023)
-
Figure China Vaccine Conjugate Market Size and Growth Rate of Influenza (2018-2023)
-
Figure China Vaccine Conjugate Market Size and Growth Rate of Others (2018-2023)
-
Figure China Vaccine Conjugate Market Size and Growth Rate of Pneumococcal (2018-2023)
-
Table China Vaccine Conjugate Production Volume by Region (2018-2023)
-
Table China Vaccine Conjugate Production Volume Share by Region (2018-2023)
-
Figure China Vaccine Conjugate Production Volume Share by Region (2018-2023)
-
Table China Vaccine Conjugate Production Value by Region (2018-2023)
-
Table China Vaccine Conjugate Production Value Share by Region (2018-2023)
-
Figure China Vaccine Conjugate Production Value Share by Region (2018-2023)
-
Table China Vaccine Conjugate Sales Volume by Region (2018-2023)
-
Table China Vaccine Conjugate Sales Volume Share by Region (2018-2023)
-
Figure China Vaccine Conjugate Sales Volume Share by Region (2018-2023)
-
Table China Vaccine Conjugate Sales Value by Region (2018-2023)
-
Table China Vaccine Conjugate Sales Value Share by Region (2018-2023)
-
Figure China Vaccine Conjugate Sales Value Share by Region (2018-2023)
-
Table North China Vaccine Conjugate Production Volume by Type (2018-2023)
-
Table North China Vaccine Conjugate Production Volume Share by Type (2018-2023)
-
Figure North China Vaccine Conjugate Production Volume Share by Type (2018-2023)
-
Table North China Vaccine Conjugate Sales Volume by Application (2018-2023)
-
Table North China Vaccine Conjugate Sales Volume Share by Application (2018-2023)
-
Figure North China Vaccine Conjugate Sales Volume Share by Application (2018-2023)
-
Table Central China Vaccine Conjugate Production Volume by Type (2018-2023)
-
Table Central China Vaccine Conjugate Production Volume Share by Type (2018-2023)
-
Figure Central China Vaccine Conjugate Production Volume Share by Type (2018-2023)
-
Table Central China Vaccine Conjugate Sales Volume by Application (2018-2023)
-
Table Central China Vaccine Conjugate Sales Volume Share by Application (2018-2023)
-
Figure Central China Vaccine Conjugate Sales Volume Share by Application (2018-2023)
-
Table South China Vaccine Conjugate Production Volume by Type (2018-2023)
-
Table South China Vaccine Conjugate Production Volume Share by Type (2018-2023)
-
Figure South China Vaccine Conjugate Production Volume Share by Type (2018-2023)
-
Table South China Vaccine Conjugate Sales Volume by Application (2018-2023)
-
Table South China Vaccine Conjugate Sales Volume Share by Application (2018-2023)
-
Figure South China Vaccine Conjugate Sales Volume Share by Application (2018-2023)
-
Table East China Vaccine Conjugate Production Volume by Type (2018-2023)
-
Table East China Vaccine Conjugate Production Volume Share by Type (2018-2023)
-
Figure East China Vaccine Conjugate Production Volume Share by Type (2018-2023)
-
Table East China Vaccine Conjugate Sales Volume by Application (2018-2023)
-
Table East China Vaccine Conjugate Sales Volume Share by Application (2018-2023)
-
Figure East China Vaccine Conjugate Sales Volume Share by Application (2018-2023)
-
Table Northeast China Vaccine Conjugate Production Volume by Type (2018-2023)
-
Table Northeast China Vaccine Conjugate Production Volume Share by Type (2018-2023)
-
Figure Northeast China Vaccine Conjugate Production Volume Share by Type (2018-2023)
-
Table Northeast China Vaccine Conjugate Sales Volume by Application (2018-2023)
-
Table Northeast China Vaccine Conjugate Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Vaccine Conjugate Sales Volume Share by Application (2018-2023)
-
Table Southwest China Vaccine Conjugate Production Volume by Type (2018-2023)
-
Table Southwest China Vaccine Conjugate Production Volume Share by Type (2018-2023)
-
Figure Southwest China Vaccine Conjugate Production Volume Share by Type (2018-2023)
-
Table Southwest China Vaccine Conjugate Sales Volume by Application (2018-2023)
-
Table Southwest China Vaccine Conjugate Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Vaccine Conjugate Sales Volume Share by Application (2018-2023)
-
Table Northwest China Vaccine Conjugate Production Volume by Type (2018-2023)
-
Table Northwest China Vaccine Conjugate Production Volume Share by Type (2018-2023)
-
Figure Northwest China Vaccine Conjugate Production Volume Share by Type (2018-2023)
-
Table Northwest China Vaccine Conjugate Sales Volume by Application (2018-2023)
-
Table Northwest China Vaccine Conjugate Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Vaccine Conjugate Sales Volume Share by Application (2018-2023)
-
Table SutroVax Inc Company Profile
-
Table SutroVax Inc Vaccine Conjugate Revenue, Price and Gross (2018-2023)
-
Table Fablife Company Profile
-
Table Fablife Vaccine Conjugate Revenue, Price and Gross (2018-2023)
-
Table Sanofi Pasteur SA Company Profile
-
Table Sanofi Pasteur SA Vaccine Conjugate Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Vaccine Conjugate Revenue, Price and Gross (2018-2023)
-
Table GlaxoSmithKline plc Company Profile
-
Table GlaxoSmithKline plc Vaccine Conjugate Revenue, Price and Gross (2018-2023)
-
Table Sinovac Biotech Ltd Company Profile
-
Table Sinovac Biotech Ltd Vaccine Conjugate Revenue, Price and Gross (2018-2023)
-